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Objectives: This study aims to develop a high-sensitivity antibody diagnostic kit
that will enable a rapid and accurate detection of Cryptospofidium parvum and
Giardia lamblia in patients with diarrhea.
Methods: The cultivated C. parvum oocysts and G. lamblia cysts in each calf and
dog were injected to mice to obtain antibodies, which were titrated. Spleen cells
of the immunized mouse were separated and blended with myelomas to produce
hybrid cell lines that form monoclonal antibodies. Using ELISA method, anti-
bodies that specifically respond to C. parvum and G.lamblia were then selected.
The cells were injected into the abdominal cavity of a BALB/c mouse to isolate
hydrops abdominis containing high level of antibodies. The IgG antibody was
purified using protein G gel.
Results: The detection limit of monoclonal antibodies for Cryptosporidium
parvum and Giardia lamblia was 125 oocysts/mL and 1250 cysts/mL, respec-
tively. In addition, during testing they did not show cross-reactivity to viruses
(n Z 15), bacteria (n Z17), and parasites (n Z 9).
Conclusion: The rapid diagnostic antibody kit developed in this study, which
specifically responds to C. parvum and G. lamblia, will be useful in detecting and
monitoring diarrheal infections.1. Introduction
Cryptosporidium parvum and Giardia lamblia have
been recognized as the causative agents of diarrhea in
humans worldwide [1]. These protozoans areted under the terms of the
) which permits unrestrict
operly cited.
ase Control and Preventiontransmitted by the fecaleoral route and most commonly
by the consumption of contaminated food and water [2].
Infections are mostly seen in young children and
immunocompromised patients. These infections are seen
in both developing countries and developed countries.Creative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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increased risk of transmission, due to urban crowding
and poor sanitation facilities [3].
Among the Korean population, C. parvum and
G. lamblia account for less than 1% of diarrheal cases;
however, the rate of C. parvum infection has been on the
rise, and one case of infection by G. lamblia was re-
ported in Jinan-gun, Jeollabuk-do Province, among
people who drank water from a nearby valley [4,5].
Traditional diagnostic methods for treating these
parasitic infections include testing fecal samples for the
pathogen and must include concentration procedures
along with specific staining techniques for proper
microscopic detection and identification of the parasite
[6]. These methods are laborious, take a long time, and
require specialized and trained personnel. Although
other techniques such as immunofluorescence micro-
scopy improve sensitivity, they are expensive and
laborious, and are not routinely available in all labo-
ratories [7]. In addition, molecular techniques to detect
Cryptosporidium, Giardia include polymerase chain
reaction (PCR) and real-time PCR that provide high
sensitivity and specificity, but these techniques are time
consuming and require expensive specialized equip-
ment [8,9].
Therefore, there is a need for a simple yet accurate
method of detection for rapid and effective treatment of
diarrheal infection. The aim of this study was to develop
a new antigen diagnostic kit and evaluate its efficiency
in detecting C. parvum and G. lamblia infections. In
addition, the usefulness of this rapid diagnostic kit was
compared with enzyme-linked immunosorbent assay
(ELISA) and other diagnostic kits that are commercially
available.2. Materials and Methods
2.1. Preparation of immunogen
C. parvum oocyst was purchased from MEGACOR
(MEGACOR Diagnostik GmbH, Hoerbranz, Vorarl-
berg, Austria) and orally injected to a month-old calf.
From the 2nd day onward, the stool samples were
examined with a Crypto-Strip (Coris BioConcept,
Gembloux, Belgium). The samples were floated onFigure 1. Selection of optimal pair for anti-Cryptsaline solution, kept still for 2 hours, and the upper layer
was extracted. The collected fluid was centrifuged and
the precipitation was cleansed three times with sterilized
saline solution to retrieve C. parvum oocysts.
G. lamblia cyst was purchased from American Type
Culture Collection (Manassas, VA, USA; catalog num-
ber: PRA-242) and orally injected to a 2-month-old
beagle dog. From the 2nd day onward, the stool samples
were examined with a Giardia-Strip (Coris BioConcept).
The cysts were retrieved similar to the procedure
described for C. parvum.
2.2. Administration of adjuvant emulsions
Samples of C. parvum and G. lamblia were sepa-
rately mixed with complete Freund’s adjuvant (Sigma
Aldrich). Approximately 200 mg of the emulsion was
injected four times into the tail vein of a mouse at a 2-
week interval. While complete adjuvant was used for
the first injection, incomplete adjuvant was used for the
rest of the injections. Overall, three intravenous in-
jections were administered into the tail vein of the
mouse.
2.3. Serum collection, titration, and cell fusion
A small amount of blood was drawn from the tail of
the immunized mouse; subsequently, the serum was
separated and ELISA was used for titration of the
serum sample. The immunogen was adhered to the
ELISA plate at a concentration of 1 mg/mL. An anti-
serum was then diluted in ten stages (10, 100, 1000
times, and so on) by adding 1% bovine serum albumin
for reactivity test. Secondary reactivity test was con-
ducted using the goat antimouse immunoglobulin
G (IgG) peroxidase, and 3,30,5,50-tetramethylbenzidine
substrate (Thermo Fisher Scientific Inc., Rockford, IL,
USA) was added for color development. The cut-off
rate was set at three times the absorbance level of a
normal mouse serum. At a dilution factor greater than
1000, if the sample shows antibody titer above the cut-
off value, cell fusion was performed. Spleen cells of the
immunized mouse were separated and blended with
myelomas to produce hybrid cell lines that form
monoclonal antibodies. Using ELISA method, anti-
bodies that specifically respond to C. parvum were then
selected. The cell lines were cultured in a largeosporidium parvum by the detection limit test.
Figure 2. Selection of optimal pair for anti-Giardia lamblia by the detection limit test.
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cavity of a BALB/c mouse to isolate hydrops abdom-
inis containing high level of antibodies. The IgG anti-
body was purified using protein G gel.
2.4. Pharmaceutical engineering test
A solution containing 40-nm gold nanoparticles was
prepared. To 1 mL of this solution, 20 mg of the anti-
body was added. The pH levels were properly adjusted
for each antibody and at the end of the preset time, a
solution of polyethylene glycol was added to stop the
reaction and obtain gold conjugates. A matching test
was then carried out for the purified antibody and the
gold conjugates to identify the optimal pair of antibodies
for the test and the gold conjugates.3. Results
3.1. Development of C. parvum-specific antibody
From the serum of the immunized mouse, three an-
tibodies with the highest level of anti-Cryptosporidium
titers were selected for fusion (data not shown); among
the hybridomas produced, seven cells (numbers 1e7)
with the highest anti-Cryptosporidium titers in the su-
pernatant were selected to test detection limit by anti-
body dilution. According to the test results, cell number
1 (1E6) and cell number 2 (5D2) were selected as an-
tibodies for the final test and the gold conjugates,
respectively (Figure 1).
3.2. Development of G. lamblia-specific antibody
From the serum of the immunized mouse, five anti-
bodies with the highest level of anti-CryptosporidiumTable 1. Comparison of imported detection kits and antibody d
CORIS BioConcept
Crypto-Strip
CORIS BioConc
Giardia-Strip
Positive Negative Positive Nega
Antibody
developed
in this study
Positive 8 0 9 0
Negative 0 30 0 30
ELISA Z enzyme-linked immunosorbent assay.were selected for fusion (data not shown); among the
hybridomas produced, eight cells (numbers 1e8) with
the highest anti-Cryptosporidium titer in the supernatant
were selected to test detection limit by antibody dilution.
According to the test results, cell number 3 (4E12) and
cell number 5 (2D5) were selected as antibodies for the
final test and the gold conjugates, respectively (Figure 2).
3.3. Detection limit test for C. parvum and
G. lamblia
In order to test the detection limit of C. parvum, the
samples were tested with two imported rapid detection
kits, namely, Crypto-Strip and Cryptosporidium Antigen
Detection ELISA (Diagnostics Automation, Inc.). The
results of the comparative test were that the solution
developed in this study, Crypto-Strip, and Cryptospo-
ridium Antigen Detection ELISA showed positive con-
centration for 12.5 oocysts/0.1 mL, 50 oocysts/0.1 mL,
and 12.5 oocysts/0.1 mL, respectively (data not shown).
In case of G. lamblia, the detection limit was 125 cysts/
0.1 mL, 250 cysts/0.1 mL, and 125 cysts/0.1 mL,
respectively (data not shown).
3.4. Sensitivity and specificity test for field
sample
The sensitivity and specificity tests for the field
samples obtained from Professor Dr Yeong-Min Lee
(Department of Internal Medicine, Veterinary College
of Jeju National University) were also conducted. The
antibody developed in this study showed the same level
of sensitivity and specificity when compared with the
imported kits (tested using cow stool samples for C.
parvum and dog stool samples for G. lamblia) (Table 1).eveloped in this study
ept Cryptosporidium
antigen detection ELISA
Giardia lamblia
antigen detection ELISA
tive Positive Negative Positive Negative
8 0 9 0
0 30 0 30
Table 2. Results of cross-reactivity testing for Cryptosporidium parvum and Giardia lamblia antigen rapid kit against 15
viruses
Panel Culture Strain
Concentration
(mg/mL) Result Reference
Virus Adenovirus 3 GB 1 d ATCC VR3
Adenovirus 6 Tonsil 99 1.2 d ATCC VR6
Adenovirus 21 AV-1645/128 1 d ATCC VR256
Cytomegalovirus Towne 1.5 d ATCC VR977
Echovirus 2 Cornelis 1.3 d ATCC VR1039
Echovirus 5 Noyce 0.9 d ATCC VR1043
Echovirus 11 Gregory 1 d ATCC VR41
Herpes simplex virus 1 F 0.25 d ATCC VR733
Herpes simplex virus 2 G 0.115 d ATCC VR734
Mumps virus Enders 1.8 d ATCC VR1379
Parainfluenza virus 1 Sendai 1.5 d ATCC VR105
Parainfluenza virus 2 CA/Greer 3.9 d ATCC VR92
Parainfluenza virus 3 C243 1.93 d ATCC VR93
Respiratory syncytial
virus
A-2 1 d ATCC VR1540
Respiratory syncytial
virus
Long 0.42 d ATCC VR26
ATCC Z American Type Culture Collection.
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A cross-reactivity test was conducted for 15 viruses,
17 bacteria, and nine parasites. The samples were
diluted 100 times by extracting the stool samples. The
samples did not show any cross reactivity (Tables 2e4).Table 3. Results of cross-reactivity testing for Cryptosporidium
different bacteria
Panel Culture
Concentratio
(cells/mL)
Bacteria Bordetella pertussis 1  108
Enterococcus faecalis 1  108
Escherichia coli 1  108
Haemophilus influenzae 1  108
Klebsiella pneumoniae 1  108
Legionella pneumophila 1  108
Mycobacterium avium 1  108
Mycobacterium
intracellulare
1  108
Mycobacterium
tuberculosis
1  108
Mycoplasma
pneumoniae
1  108
Neisseria gonorrhoeae 1  108
Neisseria meningitidis 1  108
Proteus vulgaris 1  108
Pseudomonas
aeruginosa
1  108
Staphylococcus aureus 1  108
Streptococcus
pneumoniae
1  108
Streptococcus pyogenes 1  108
ATCC Z American Type Culture Collection; KTCC Z Korean Type Cultur4. Discussion
The World Health Organization ranks diarrheal dis-
ease as the second most common cause of morbidity and
mortality in children in the developing world. Theparvum and Giardia lamblia Ag rapid test kit against 17
n Result (dilution ratio
1:100) Reference
d ATCC 8467
d ATCC 4079
d ATCC 25922
d ATCC 8142
d ATCC 4208
d ATCC 33153
d ATCC 15769
d KTCC 9514
d ATCC 27294
d ATCC 15492
d ATCC 31953
d ATCC 6250
d ATCC 6361
d ATCC 27853
d ATCC 29213
d ATCC 19615
d ATCC 4012
e Collection.
Table 4. Results of cross-reactivity testing for the Cryptosporidium parvum and Giardia lamblia Ag rapid test kit against nine
different parasites
Panel Culture Concentration (parasite/mL)
Result (dilution
ratio 1:100) Reference
Parasite Entamoeba histolytica 1  104 d ATCC 30190
Microsporidia 1  104 d ATCC 50040
Cyclospora cayetanensis 1  104 d Positive sample in this study
Plasmodium vivax 1  104 d Positive sample in this study
Plasmodium falciparum 1  104 d Positive sample in this study
Toxoplasma gondii 1  104 d ATCC 50174
Trypanosoma cruzi 1  104 d ATCC 50791
Leishmania donovani 1  104 d ATCC 50127
Leishmania infantum 1  104 d ATCC 50134
ATCC Z American Type Culture Collection.
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parasites. Among parasites, Entamoeba histolytica, G.
lamblia, and Cryptosporidium spp. are considered to be
the most common and important [3].
G. lamblia is considered as one of the main nonviral
causes of diarrhea in developed countries [10]. Crypto-
sporidiosis is a frequent cause of diarrheal disease in
humans. In developing countries, Cryptosporidium spp.
infections occur mostly in children younger than 5 years
of age, with a peak in children younger than 2 years of
age [11]. In immunodeficient humans, especially in-
dividuals with human immunodeficiency virus infection/
acquired immunodeficiency syndrome, cryptosporidi-
osis can be associated with chronic, potentially life-
threatening diarrhea [11].
In Korea, C. parvum and G. lamblia infection is on
the rise, which was not the case before [4,5,12]. And yet,
there is no standard test method for the detection and
diagnosis of the protozoan that causes acute diarrhea.Figure 3. Test procedure for CryptosporidiumFor these two kinds of parasites, diagnosis by
analyzing microscopic results is neither sensitive nor
specific. Individual antigen detection tests and PCR tests
are now available for these parasites, but multiplex an-
tigen detection tests are still under development [13].
The PCR assay for the detection of G. lamblia and
Cryptosporidium spp. developed in this study is a useful
alternative for diagnosis of these parasites.
In recent years, antigen-detection assays, such as
enzyme immunoassays, various PCR methods, and
immunochromatography, to detect Cryptosporidium
and Giardia have been developed [13e15]. A number
of products with a good range of sensitivity and
specificity are commercially available. For the diag
nosis of Cryptosporidium, discrepancies found be-
tween microscopy results and PCR can be interpreted
as follows: in samples that were positive by micro-
scopy and negative by PCR, this technique will fail
because of the low number of oocysts present in theparvus and Giardia lamblia rapid test kit.
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inhibitory substances. By contrast, in samples that
were negative by microscopy, with a low number of
oocysts, and without the presence of PCR-inhibitory
substances, the greater sensitivity of this technique
permits the detection of Cryptosporidium [8].
In the case of Giardia detection, microscopy was the
reference technique, but PCR was found to be 100 times
more sensitive than ELISA in detecting this parasite [9].
In this study, an antibody diagnostic kit for C. par-
vum and G. lamblia was developed and compared with
commercial kits. The kit will enable early detection and
diagnosis of diarrheal infections, thereby preventing
collective waterborne protozoans.
Appendix
For the testing method, stool (feces) samples were
used. The testing steps are as follows (Figure 3):
 Open the tube containing the solution.
 Draw the assay diluents up to the fill line marked on
the dropper, and transfer them to the sample-
collection tube.
 Take a portion of the sample with a swab and dip it
into the tube; swirl the swab at least 10 times.
 Discard the swab.
 Cap the tube.
 Take the test device out of the silver foil, and place
it on an even surface.
 Add four to five drops of the diluted sample into the
sample well.
 Analyze the outcome after 10e20minutes. A positive
reactivity can be seen immediately in some cases.
Acknowledgments
This work was supported by a grant from the Korea
National Institute of Health (Grant No. NIH-091-4800-
4847-300), National Research and Development Pro-
gram, Ministry of Health and Welfare, the Republic of
Korea.References
1. Marshall MM, Naumovitz D, Ortega Y, Sterling CR. Waterborne
protozoan pathogens. Clin Microbiol Rev 1997 Jan;10(1):67e85.
2. Fleckenstein JM, Bartels SR, Drevets PD, et al. Infectious agents
of food- and water-borne illnesses. Am J Med Sci 2010 Sep;
340(3):238e46.
3. Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium
join the ‘Neglected Diseases Initiative’. Trends Parasitol 2006
May;22(5):203e8.
4. Lee MY, Cho EJ, Lee JH, et al. A survey of Cryptosporidium
oocysts in water supplies during a 10-year period (2000e2009) in
Seoul. Korean J Parasitol 2010 Sep;48(3):219e24.
5. Lee MY, Cho EJ, Lee JH, et al. A ten-year survey of Giardia cysts
in drinking water supplies of Seoul, the Republic of Korea. Korean
J Parasitol 2011 Mar;49(1):9e15.
6. Garcia LS. Diagnostic medical parasitology. Washington, DC:
ASM Press; 1997.
7. Garcia LS, Shimizu RY. Evaluation of nine immunoassay kits
(enzyme immunoassay and direct fluorescence) for detection of
Giardia lamblia and Cryptosporidium parvum in human fecal
specimens. J Clin Microbiol 1997 Jun;35(6):1526e9.
8. Kehl KS, Cicirello H, Havens PL. Comparison of four different
methods for detection of Cryptosporidium species. J Clin Micro-
biol 1995 Feb;33(2):416e8.
9. Lee JH, Lee J, Park SJ, et al. Detection and genotyping of Giardia
intestinalis isolates using intergenic spacers(IGS)-based PCR.
Korean J Parasitol 2006 Dec;44(4):343e53.
10. Ali SA, Hill DR. Giardia intestinalis. Curr Opin Infect Dis 2003
Oct;16(5):453e60.
11. Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis:
epidemiology and impact. Microbes Infect 2002 Aug;4(10):
1059e66.
12. Park JH, Kim HJ, Guk SM, et al. A survey of cryptosporidiosis
among 2,541 residents of 25 coastal islands in Jeollanam-Do
(Province), Republic of Korea. Korean J Parasitol 2006 Dec;
44(4):367e72.
13. Gon˜i P, Martı´n B, Villacampa M, et al. Evaluation of an immu-
nochromatographic dip strip test for simultaneous detection of
Cryptosporidium spp, Giardia duodenalis, and Entamoeba histo-
lytica antigens in human faecal samples. Eur J Clin Microbiol
Infect Dis 2012 Aug;31(8):2077e82.
14. Haque R, Roy S, Siddique A, et al. Multiplex real-time PCR assay
for detection of Entamoeba histolytica, Giardia intestinalis, and
Cryptosporidium spp. Am J Trop Med Hyg 2007 Apr;76(4):
713e7.
15. Minak J, Kabir M, Mahmud I, et al. Evaluation of rapid antigen
point-of-care tests for detection of Giardia and Cryptosporidium
species in human fecal specimens. J Clin Microbiol 2012 Jan;
50(1):154e6.
